Thomas Gad, See remarks at Y-mAbs Therapeutics, Inc. (YMAB), sold 147,228 shares at $10.89 ($1.6M) on 2022-01-19, disclosed to the SEC on 2022-01-20.
Open-market sale of $1.6M YMAB by See remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.46 | 400 | $5K | 0.3% |
| 2 | $11.54 | 8,000 | $92K | 5.7% |
| 3 | $10.89 | 69,414 | $756K | 47.0% |
| 4 | $10.89 | 69,414 | $756K | 47.0% |
| Total | $10.93 avg | 147,228 | $1.6M | 100% |
| Filing → |
| YMAB | SELL | 2024-06-11 | $841K | — | Filing → |
| YMAB | SELL | 2024-05-23 | $396K | — | Filing → |
| YMAB | SELL | 2024-03-07 | $128K | — | Filing → |